Oncology Institute Inc
NASDAQ:TOI

Watchlist Manager
Oncology Institute Inc Logo
Oncology Institute Inc
NASDAQ:TOI
Watchlist
Price: 3.03 USD -6.19% Market Closed
Market Cap: 298.1m USD

Wall Street
Price Targets

TOI Price Targets Summary
Oncology Institute Inc

Wall Street analysts forecast TOI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TOI is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

Lowest
Price Target
6.06 USD
100% Upside
Average
Price Target
7.14 USD
136% Upside
Highest
Price Target
8.4 USD
177% Upside
Oncology Institute Inc Competitors:
Price Targets
RAINBOW
Rainbow Children's Medicare Ltd
26% Upside
BSL
Raffles Medical Group Ltd
22% Upside
KPJ
KPJ Healthcare Bhd
13% Upside
BKD
Brookdale Senior Living Inc
5% Upside
SHALBY
Shalby Ltd
12% Upside
MAXHEALTH
Max Healthcare Institute Ltd
22% Upside
NH
Narayana Hrudayalaya Ltd
2% Upside
FPHB
Focus Point Holdings Bhd
18% Upside

Revenue
Forecast

Revenue Estimate
Oncology Institute Inc

For the last 5 years the compound annual growth rate for Oncology Institute Inc's revenue is 20%. The projected CAGR for the next 3 years is 20%.

20%
Past Growth
20%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Oncology Institute Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
94%
Average Beat

Net Income
Forecast

Net Income Estimate
Oncology Institute Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TOI's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for TOI is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

What is Oncology Institute Inc's Revenue forecast?
Projected CAGR
20%

For the last 5 years the compound annual growth rate for Oncology Institute Inc's revenue is 20%. The projected CAGR for the next 3 years is 20%.

Back to Top